Pharmacology Clear and Simple: A Guide to Drug Classifications and Dosage Calculations
Description:
2 books in one!
- Pharmacology
- Dosage calculations
Save time and money with two books in one! Half pharmacology, half dosage calculations—plus an intensive yet accessible review of basic math!
Here’s the must-have information you need to gain a solid understanding of pharmacology and administer medications safely. A body systems approach to pharmacology with a basic math review and a focus on drug classifications prepare you for the clinical situations in which specific drugs are used.
Thoroughly updated and revised, the 2nd Edition of this worktextoffers a consistent chapter structure that progresses from key terms and behavioral objectives through the chapter content to application and review exercises.
Plus, drug calculation activities on the BONUS CD-ROM help you overcome your fears and develop your skills.
Confidently handle your toughest challenges in any clinical setting with Pharmacology Clear & Simple, 2nd Edition!
Best prices to buy, sell, or rent ISBN 9780803625884
Frequently Asked Questions about Pharmacology Clear and Simple: A Guide to Drug Classifications and Dosage Calculations
The price for the book starts from $5.99 on Amazon and is available from 42 sellers at the moment.
If you’re interested in selling back the Pharmacology Clear and Simple: A Guide to Drug Classifications and Dosage Calculations book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Pharmacology Clear and Simple: A Guide to Drug Classifications and Dosage Calculations book, the best buyback offer comes from and is $ for the book in good condition.
The Pharmacology Clear and Simple: A Guide to Drug Classifications and Dosage Calculations book is in very low demand now as the rank for the book is 1,758,197 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.